Investors

• President's Message
• Financial Results
• Investor Events
• Integrated Report
• Company Strategy
• ESG

• Apr. 08, 2024 InfoNotice Concerning the start of the process to return certain land and building in Shenzhen 
• Mar. 28, 2024 Info(Progress of disclosure matters) Notice Concerning the Impact of the 2024 Noto Peninsula Earthquake 
• Mar. 28, 2024 InfoNotification for the Candidates for the Board of Directors 
• Mar. 26, 2024 InfoNotice Regarding Completion of Share Repurchase and Cancellation of Treasury Shares 
• Mar. 08, 2024 InfoNotice Regarding Rescission of Definitive Agreement to Acquire shares of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. 

View All

• Management Policies
  • President's Message
  • Corporate Philosophy
  • Company Strategy
  • Top Management
  • Articles of Incorporation and Share Handling Regulations
  • Disclosure Policy
  • Business Risks
  • Company Presentation
• IR Library
  • Financial Results
  • Investor Events
  • Corporate Disclosure
  • Securities Reports
  • Integrated Report
  • Olympus Medical Business
• Stock Information
  • Shareholders' Information
  • General Meeting of Shareholders
  • Shareholder Returns
  • Corporate Bonds and Ratings
  • Analyst Coverage
• Financial Data
  • Annual Data
  • Quarterly Data
  • Download Financial Data
• ESG
  • Olympus Group ESG
  • Environment
  • Social
  • Governance
• About Us
  • Olympus’ Value Creation Model
  • Fact Sheet
  • About Olympus

Annual Schedule

* The schedule may be subject to change.

• Internet IR Commendation Award 2023 by Daiwa Investor Relations Co. Ltd.
• AAA Website, All Japanese Listed Companies' Website Ranking 2023, Overall and Sector by Nikko Investor Relations Co.,Ltd.